nghiên cứu đánh giá thay đổi nồng độ hbsag sau điều trị
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (239.72 KB, 36 trang )
1
2
ĐẶT VẤN ĐỀ
!"#$%&'()*((+
%,+-%./
%,0-1 2342!5+6278%9"
$:-$;-<=()>(?@ABC!DEF6G9
$%A HI%1#+6!JK
$:L1$:9M< N"
I%-O!
+-$:L--P-QIRI:P-SA2-"
+T@%I2"N1-U342
DEF6G-V< N"@A!W-X-$:L
$Y--><-<UZ0[$:L\ XY ]6<
O1$:^@0L-2W-$+@0L--4U$X,
8WAI:%I!6<O-W-0_-1
-707`07^O--%!$%2-<aX-$Y-
bJc -d-$:L]e7f7f2 770
7f7f>-<O107207f277-2
7I0727f-<O. 6<$:^@0L--<
+9"-:W-0[ [2+9"X,8U7
c2J42 -g!EX-O--%1
X2W-0[ [-N0h8i02-j+8W
X--/!
E7f0 3f7kEJbl2-<O--%7-i
Y-2X-4$X,2+9"$:L-$Y-bJc-1 K
$:Lm>((n!$%2EJb0
3
X-8W1<X-O--%2
-V--<o:T8WX--SA!
E$:L29$U$:Lp-,-,$%
[-AJ6c!E1Q2AJ6c
_-<j+%U342DEF6G!q%X9$L
I+$Y-I%$%N$J6c^8$;<L
k J6cl%I!6--<8rK$LY J6c2
-W-W-"-O-<P49;$Ac
W J6c!:-4#8M-T;$Ac "
W0L-s-S J6c%I!TK$LY
AcW$s#M-S-W--ON$!tUm
-O$N-SE7-oIX/=ua($Y- WU
I#v7=uu*+-Z0[;$Ac$U70w$W O
$:L2+$s-<4=((L"K:^-S;$
Ac!E$<-<:-O$WW
$H;$Ac$:L!+6-^--<:
-O:1$:!TK27%-O,[-]
1. xW-$L$H;$Ac$:LE7f#I+
GtEq8<I++-
2. xW-$LX49$H;$Ac-W--y
$W O<2@0L-$:LIQEJb#I+
70w$:LGtEq8<I++
-
3. zWW-SEJb#-W-I+
70w$:LGtEq8<I++-!
4
CHƯƠNG I. E{6F|Dc6
1.1. z-4:AI+
A-M7 007!A7 0 A!6< -<8"/
-L$P,+$$d-P-8}!;$Y-='/#~
>(2>*W#~n(2•W#+$ ^2a#**!6<-y
@I+##€$L,I+-y#%I
!
1.1.1. 1p--SA
7AQUUJ7$8*>!J7
-y-^M-7- 0!J7-<I
IM-I#, 8WI:Ac!6-<8W
A-c2^cJ6=Y0Y04•28o3•2
-< 77!cJ6Ys<1-" 7Am*8$M-
#‚2G2x2!
ƒt‚];&hG7‚=2G7‚>2‚-<^8#$0L-s!
ƒtx]s< 7-<8"/W-$$%P WU
W9A!
ƒt]-LW-+%A7c!
ƒtG]s< 77-S!
W-0 NZA-<&] NZ8WI:2 NZ
2-y
1.1.2. F7 7 IX$L„-S7 7A
A+-<n7 7A$s$Y-3W-$L]c222J2…2b2F2ABC!
E$<]
F7 7c]GW+-S%#h•-†-S†•-r!
F7 72] HI7#0I"$Lzo6g
F7 7J] IXM42#<--p2-#h
6†•-G!
F7 7…]hE6G!
F7 7b]8oN112 W+#6Er!
GIX7 7-^ [--W-$Y00$s3"!
E%U-SI+-<\42$W O$:L<X-
8W-KY-I+IL@7 7,
@7 7!
5
1.1.3. ‚#-8}$X-SA
6I,-#-SA%II•$NIQ•
8%2K I2^-S ZA,%I7
9TNY]
,-=]EW-RIM-$U-7- 0K -S%I
,->]F" <Z->^cJ67
-i Y--S$U J6c-V" <
cJ6 772 J6c#@•-U2_$Uc‡6
77ee-S%I1-"c‡6)A!+-Z->^
J6c J6c;*-o$]
ƒAYJ6ckƒl
ƒEW- 78o_mJ6ck~lI-70
8o_mJ6ckƒl
ƒm0-X8o-N%$U-X-SJ6c^!
ƒ6X>$-X-S>^J6c
1.1.4. W-87-SA%
1.1.4.1. tWI:Ac8WU8WAck~Al
Ac-<I"-1 7231+1,,-8-<+
-O2/-0NI%1*)nN8Um8-<+
-O!‚P+0+-SAcIQ-O-<„ˆ1-SP
@A!6%•W_-^AcI+$s#
!
<X4Y @Ac2-<
U;$1 8rK3i+- W+$Y--
AcIL^I#Y~A4!
tWU~A31+>~=•N88o W+$Y-
Ac!E$<8WUe~A31+$-1 2
8WUeF~A31+4;4!‚P31
+8WU~A01+-ORI+$s$Y--"+2<
-<W-0[-XW@A!
c~A-<U$Y--W-P0@A-
$$Y--S•-3 ^!c~A-<8"
6
/@0L-X$!t6@A$<31+~
AT-W-Y N,8o-<IU++-O
H4oI+M-8o$W8U!EoAc
~A>011%m_2ˆ-W
04T-W8Y-!E-<X4Y
-"Ac~A-h04--h!F$-ZH
T-">011-31+!E$-S%T@
A218I+Ih W-<Ackƒl-4U8WU
~Akƒl-$S$UAck~l2-Ack~l
-W-P0W-$-S$I%h7‚-4U
8o~A!tAc~A-h2$U-d$W
-hA-AJ6cBC
1.1.4.2. tWwA-c8WU8WA-ck~A-l
A-c8W -1p--S N -7- 02T A-c
8o-<$ 7 0+A7c8o$Y-I%
8R%I!JA-c-y31+%I-y-<U
W+$Y-8%!6%%I-<A-c
T I % I -V -< Ac ; $ J6c
77o/-!
c~A-;>]e~A-~eF~A-2$<
e~A-31+,1$Y-0h$U-d$WT
@A-1 !E$-S%T@
A!t;$e~A-"0NT;$eF~A-
/0N!eF~A-$Y-Z0[$U3W-$L:Z-<
@A$-I+Y Ack~l!EX
4Y -<$YIh WW WI+
Te-<U042TK-<UN_$Y%U-S
-1 B&&C
1.1.4.3. tW^A7c8WU8WA7k~A7l
7
A7c8o-<-O-/-1p-A2P-%
$Y-Z0[%XYI+$WW+9"$:L!
A7c-<-h;X-7,A-c2MY Z
R4A-c!A7c31+Ac-<9$%P
+0+-W--y2IQ-O-S@-!
E @A-1 2-<-U$H%$X,
A7c01+IW,-$X,9WTAc#
31+~A#6-1 8RI+!BC!
56@A2A7ckƒl#$0
@0L-#$$W O@0L-!G[-<
A7ckƒl8"/--$%u(~=((?2A7ck~l8"/
--'~>(?!8W-a(?Y--;-SA7ckƒl-<
-4@A2%6$s-<~A7-<&(?Y--;
-SM-<-4IL@BC!
E-U$H%A7c9$%X%X
H@2,28U7A2-S-2$:8+8%3s2
$:8+oX!6A7cH
IT-4<A7ckƒl28U7-<j+-U$H%
-4,48U7!6$YcE/-8L- W
01+IW,-P-U$H%A7cBC!
E8o "1-"-W-Y A7ck~l$:-<ˆ
I+$%U!E631+$I%#XL
7xh-7~ 7-SAJ6c2-W-$I%
O--%PHY -SA7c8--9WT
-SAJ6c!
c)AI731+#$ [-;!t-<8WU~
A7W01+-ORI+$$Y--"+!Eo
8~A7kƒlTA7ck~l!E%;$~A7
-$ST-<U;04-"A7c~
A7!E4PK:Y -"$:!
8
EN1-U$H%,A7c31+~A7P
8"=()='?`/2j+-<U-49NU
6$Y-$:LX-8W!E7X-O
9WT-U$HA7c00hX-8oI:IQ9W
T-U$HP!W--O6E|X--1
-<U3"+Y$"-:mA7ck~lA7ckƒl2m~
A7kƒl~A7k~l2$-I+6$;2$:
L<-10h--0BC!
1.1.5. +
$Y-:7-$WT0[-!t%
9"P@h‰0_$%4W-K-S O-
K9"I+-<IU++-O-I+8o+-O!
+-<U@0L-,A--<UN
I+$< WU34IUo%I!
1.1.5.1. Một số định nghĩa(AASLD 2009):
a. I+Z%I
I#@8i0!+-<U-
A7ckƒlA7ck~l!
b. ; [-]6@A,-$8o-<IQ
-O$-S-SI+:oM-2<2
M-!
c. zYIh W--1 -S]P/8o
[--S$7Š=(ND6-,>NI77
7!
d. W$]P31+#-ST
Z-W-%#0Y-I%$%-<W
Ac8o$-$s; [-
e. ‚P-A7c]1A7c#,-A7ckƒl
f. U$"%A7c]1A7c31+A7
#,-A7ckƒl~A7k~l!
9
g. ‚P#A7c]x1+#A7c4,-$
A7ck~lA7kƒl
1.1.5.2. Cơ chế bệnh sinh
W-IU+I+M--S0P
4W-+@0L--4U!A+@0L-1-o
AH4%I!W-%I J*ƒJnƒ
$Y-8-K-W- 7 07-SAI:%I
-. "O@0L-3"!W- "O@0L-"
k" <-W--872"318WUl-8%9"T
0"@0L-m "!z-I+2
$W O-S-W-%I E-%3"-X
-W-%I@A!BC!EW-X-hA34
!+34@A-<8"/ WU
IUo%I!BC
8}$X-S%I-S;*$]
~ F$=]J @0L-!E$#
8R7>~*N$0+-SI+!zX,\
428}:K 8j!F$
28o/cE28o-<+-OI+!
~ F$>]E$2 "O,+O W
S % I 3"! A7c -< U $Y- 3W- $L %
2P";$AJ6c3"!E-W-I+
IL@-1 &~*Nk-<+-Ol!zX,
-W-I+IL@2=(-4,-834
WU!
~ F$&]8o-^3"2A7cI-<U$Y-
W+!AJ6c-<U1 -8o W+$Y-2cE
-%!E$0@P-Y
I7-SI7%I-SW-S!Ac_
+0+!
10
~ F$*]E$2-<U8o$Y- W+2
-W-8W8W--S$s$Y-"31!q%X
8W-$s$Y---oK"#$%P W
U-S$;]H2,2"@0L-2$;
@,8W-!
1.1.5.3. Dịch tễ học viêm gan B
+A-% '~=(?-W-Y I+
$-X=()='?IUo%I!Ej+@
1 #0,=>H2/#=>H08%Y ,
I•$N9+T0[-!Ej+A=)>(?
%,!‚P$H-<9, 4O-@2
HI•$N@!‚P HI%-SI+#-W-8P-,j+8W-
$Y-o"]
~ tP-j+1 k(!=)>?l;02E†2c2
67‹Œ70!:9--T0[- 4O-
:-S%!
~ tP-j+ITk&~'?l;zo•-†26K"2
P-zLEA"2Ezo2!6r2Eg!
:9--2T0[-2:•--W- 4
O--!
~ tP-j+@-k=(~>(?lE|X-2e~$~7~3~2-
G -K 2 9N$" EW T J4 zo 6 g!
G4O-:-S%8}-2:•
-8}4!4T ^$Y-P-+
$N$S#h-<j+@-z0
$Hj+@A]5z2A%$s
" m =(? / =un* 3X 4 =? / =uu*2 j +
DEEF"m(!'>?3X(!=&?-h8}!B&C
11
EHI+-,2-4-U
--!E\4u(?2\7>'~'(?2,31 3y'?2
31 3y>(~&(?-4 WUI+!
1.1.5.4. Lâm sàng của viêm gan B
z-$U+-OM-$Hm:
d$%-<+-O02$%X-1 2-1 2IW
-1 $-1 2mWNI+8o
+-O$%234$
!
Giai đoạn cấp tính
ESI+m=$%•W#$-1 !
8o0U-%%0@I%-SI+!GN
,-W-I+8oIU++-O!6I+
8o0-<3, WU
4!6I+-<+-OT WUX
0!6I+028}$N-<U
-<-W-:+]-W/2I;o2o2X•2$-42+
R2YO-/hX-W0/-",hL2$
YL "•IT-!
X-1 2-1 2IW-1 -<UIU+-W-U]
~ +s
~ 6S
~ ‡X1-S
~ ‡XN
~ Ao
+-1 -V-<U8o-<I18}01+
88UO-8R7-<U%-W-+
-O]
~ ‚X•
~ 0k=(P31+-W-+-OP-U8i
0=~&Wl
~ F2:
~ J1+Ik 77l%
Giai đoạn mạn tính
12
W-6-<U8R7
NI+8o-<I18}IQ-O-SI+$
$2M-V8o-<+-O!W-6
$$-I+W$-<U
:-W-+-O]
~ W-+-O4P6-1
~ +R2-W/2I;o2$•YL28<-L
~ 1Ih-S
tUO-8R7-6@A-<U%
-W-011-SI+]201+I
2-k 07l
6634-<U-<-W-+-O]-H,2
0231%<0sŽˆ-P-9"2 h
I2p,272NI+kI0
-77l
1.1.5.5. Cận lâm sàng
Viêm gan B cấp tính
F$7/1-2-<U1 =((N,
IT2-<U$%=(((~>(((eD`#I+
$"!cE/-4c‚E!cG-<
U/--p8o/-4&N,
ITk 7l!cI-<U"•2•
%-<U/!E8}:$"I--N
-<U"2%I /2/X-$W•!EW-<
U3"%W 8o32"U-N
% !EGE8i0!
X87-<U$Y-3W-$L%
%I!Ackc7lA7c
87 $N -< U $Y- 3W-$L % !e
A-cI31+$<!zX,6$; [-2
-U$"%~A~A7$Y-9W!p-
13
eF~A-31+!66Ac8i000•
•W WU!
Viêm gan B mạn không hoạt động
F$cE2c‚EIT2A7cAJ6c
-<U!AcI2e~A-2A7cI-V-<U31
+%!
Viêm gan B mạn tính hoạt động
66 -<7 /O-$• $%
ITk•'3D6l!cE/-4c‚E!6;$cE/
1--<U$Y-9WY $Y-1 -
I+NM2-p-<U$-h,P"-O-/
k"IW2/IIW28i0GEl
AJ6c/-$!AceF~
A--ekY -<$Y8L- Wl$Y-3W-$L
%!
1.1.5.6. Tiêu chuẩn chẩn đoán bệnh viêm gan B mạn tính theo hiệp hội
nghiên cứu bệnh gan Hoa Kỳ 2009(AASLD)[ ]
Viêm gan B mạn tính
~ Ackƒl4•W
~ 6;$AJ6c%Š>((((eD`k=(‘'- 7`l2W
L1 48">((()>((((eD`k=(‘*)=(‘'- 7`l
1#2A7ck~l
~ 6;$cE/-[-8i0
~ ‚%-1-<O-$m-!
Trạng thái người lành mang HBsAg:
~ HckƒlŠ•W
~ A7ck~l2~A7kƒl
~ 6;$AJ6c’>(((eD`
~ cE2c‚E0T;$IT
~ ‚-18o-<w+
Viêm gan B khỏi
~ E:Z-1 ---<~A-`-
~A
~ Ack~l
~ 6;$AJ6c0,Ž W+
~ 6;$cEIT
14
1.1.6. Điều trị viêm gan B mạn tính
1.1.6.1. Mục tiêu điều trị
[-$:L/-8i0P
-SA"-W-I+![--X-h
W3422DEEF!
1.1.6.2. Tiêu chuẩn lựa chọn điều trị
E7+ -OI+At}>((u]
A7c AJ6c
kG‡l
keD`l
cE“ t%-$:L
kƒl Š>(((( •
>3D6
~E70w2373i$:L8
cE% [-/
~xi%#Š*(
H-cEŠ>3D68i0
-:Z$TA
~x73i$:L%AŠ>(
(((eD`% -<
H4#O-$
IT--</
34
kƒl Š>(((( ”
>3D6
E70w&~•W$:L
% 8o -< T 1
A7cP
x73i%,-8
$: L % -^
Ihk- 770l
z: L % -< 0
-%1Ih
eb6•` 7eb6•2 c2 cJ2
…E2 EJb - 0E -< U
$Y- P -M $N ! cJ
8o "P-M-
Y 8W
% j + - 8W
X-=/!c0E
8o "P-M-
Y j + 8W
o--
15
zU 8% p- $: L 8 -<
-U $" %
A7ckƒl~A7kƒl
t"$:L]
eb6•=•N
7e6b•*nN
c`cJ`…E`0E`EJb
1=/% [-1•
8 -< -U $"
%A7c
eb6•8o$W O--X
-y$L,e6b•EJb`…E
k~l Š>((( Š
>3D6
e6b•` 7e6b•2 c2 cJ2
…E2 EJb - 0E -< U
$Y-P-M$N!
c0E8o "P
-M-Y
j+8WX--
cJ8o "P-M
-Y
8W % j + -
8WX-=/
zU8%p-$:L8ow
E$:L]
eb6•` 7eb6•=/
c`cJ`…E`0E
`EJbŠ=/
eb68o$W O--X
-y$L,eb6EJb`…E
k~l Š>((( =~
>3D6
x73i%$:
L%% -<
O- $ IT -
--<01+/34
k~l •>((( ’D6 E7 0w2 $: L % A
J6c-cE/-4
ƒ`~ O- W
+$Y-
kJ77-I7
l
x4 ƒ^Ih]
AJ6cŠ>(((eD`$:
L c`cJ`…E`0E `EJb
-<UP-M$N!
c 0E 8o 0h
16
%j+8WX--!cJ
8o 0h %
8W%j+8W
X--=/!
A ’>(((eD` ] x7 3i
$:L%cE/
ƒ1Ih]
t%Y $:L-dIL-
i ! c2 0E2 cJ2
EJb2…E$Y--M!
Ui
ƒ`~ J,
Ž
W+
x4 ^Ih]70w
1Ih]-Ui
8o-N$:L8]
~ cEIT]]cE’&(D`!6]cE’=uD`!
~ cE/Š>3D6AJ6c1 -8o W+
$Y-2A7ck~l
y$L$:LA8]
~ cEŠ>3D6AJ6cŠ>((((eD`2A7ckƒl!A-]
~ cEŠ>3D6AJ6cŠ>(((eD`A7ck~l
~ x4k-^Ih-1IhlcE/`IT2AJ6c
W+$Y-!
~ ‚"@0L--<L+$:L
1.1.6.3. Các thuốc lựa chọn cho điều trị
Thuốc điều hòa miễn dịch dạng tiêm
W-X-8--+@0L-0+-W-%I
@A!6<X-j+$W O1 #6-<
;$cE,-$:L1 2"Y-28"
@0k HI%#-gl!p8o$Y-8%-W
-626341Ih!W-X-8--@
0L-$-<L+•~=>WBC
~ e7f7f~>Ikec2-1 K=uu=l
E0,0&~'N`=N
~ G77f7f~>kG72-1 K>(('l
E0,0=N`N
17
-0h+9":-/I"8o8W-2 7eb68"/
%eb6f-dI#T:K+4!
Các nicleos(t)ide
<aX-X+$s$Y-bJc -d-$:L
!W-X-$N$Y-8%-W-$:L
+ 7eb62…E2EJb!
W-I+S0hX-%X9M
"XU WU-W-$I%8WX-!BC
~ 07k… ~A2 -1 K =uunl]0 - X-
,-2=N`
~ c07fkA7 72-1 K>((>l]X2=N`270w
-O-/Kk872-7Wl
~ …7-k-07 2 -1 K >(('l] X ` 0 0L-2
=N`
~ E7I07kEŒ782-1 K>((•l]X2=N`
~ E7fk702-1 N>((nl]X2=N`!E70w
-O-/KIQ-77W!
1.1.6.4. Đánh giá đáp ứng điều trị
EXZ0[$U$LW$W O$:LI;cE%
IT2AJ6c"21AI7c-h,-<`8o
31+~AI72-"+oM--S!
"]zLˆ:$W O,X-8W-SF
$W O
‚A< F"cE$%,
IT
M- F" A % 0,
Ž W + IQ x6
G‡21 AI7c#
6-<AI7ckƒl
to $W O
W
k8o W 0[ ,
eb6l
Fe"AJ6c%’
>=(eD`1>*N
$:L!
EW W:
M-
E/ A J6c 7 ==(
eD` 8 8o % [-
18
$:L1>N3W-$L
-W-*N
oM- F"-yX$oM-
1>$U8o;+
4:X$U/34
,%,-$:L!
A zW O$S-W--d-":
<2 M- 1
Ac
1.1.6.5. Theo dõi điều trị
66$:Leb6]
~E70w7*N`N2
~E‚AAJ6c=>N2
~A7ckƒl8UA7ccA7>*N`N$:L2
6I+$:L6c]
~E70w7=>N`N2
~AJ6c=>~>*N`N2
~A7c`A7>*N$:L!
~7=>N`N2
~Ac•~=>
Y A7ck~l,AJ6c
8i0IQG‡!
W-$W O-<UM$:L]
~ 6/-8i0]1-";$AJ6c
~ 6;$cE%IT
~ <-U$"%]A7231+~A7!
~ "+T/34!
~ F"-40
Nm+ W 6c8]
~ 6A7ckƒl]-U$"%A7c8o W+
$Y-AJ6c8i0Š=>Wkeecl
~ 6A7ck~l]to W+$Y-AJ6c&NI+-W-
.•Wkeecl
~ E1 I $: L WkW O &l - $W O
NkWO•l2m-$H:4=6c-<+9"
19
-=6c8o-<$:8W-i%Z0[c202
cJkeeecl
1.1.6.6. Kháng thuốc
XIK-$:L6c8i0P-MM-
-W-$I%8WX-!Ej+$I%8WX--MM--<
9$%;$AJ6c,-$:L2P/-
2-W-$:L6c,-$<!
"]W-$Lˆ9$%8WX-8W,
L+6c]
z:8+ zLˆ
h W E/ A J6c % Š
==(k=(~f0l O- 1 1
8$$Y-$W O28%
[-$:L
‚PIK-S E/ A J6c % Š >((((
`-O-;$,-8
$:L8$s$$Y-$W O2
8_$% [-$:L
h W< E/cED68$$Y-W
LIT28_$% [-
$:L
tW:7 GW + $ I% X +
-OT8WX--S6c
$Y-9"„!
tW X- :
8UT
xW-KX+Q$I%
$Y- W+"-"k$Y-
-OIQ/;$O--%l$U
9"„6c!
‚Z0[KM6c#-W-I+
4 W ^I++9"1$UW WU8WX-
8WA!JK2I+I+XU
8o-<8"/$$Y-$W O0T8o$Y-
$:L,-W-6c2$-I+,\2k’&(Hl!t-<
U2-W-6c-<+P-$Y-S9"„!-0h8%Y
20
$:L$Y-37I+ W ^W8WX-#6@
Ae2PO•8%Y X-- "Rs#6@
A!
1.2. E7f^-S<$:L
1.2.1. JY-„M-8UW-0[-SEJb
E7f0 3f7-:, 4P-707
8o$<^!EW-0[8W-S<$Y-o"
$N/=uu&2Y-,cJ2 H$8W
-SEJbIL,#77 0728oI;
7 77!BCE/W-0[<IQ$X2EJb$s
I%$H0:X--S<27f0 32IQ-W->
7787-I7!BCJ-"%1%I-W-
-OX+$s-O/+P-1 '(N!B
C
EJb-<$Y-S 8002
IR><772$<X-P0$Y-" <N!BC
E7f$%Io99WTK I[$2$<
$Y- <I#-W--70787207787
I 7$<-<$Y-
-UI#-7070 78700
$!BCE7f0 O--%-MM-7Œ7-i Y-
J6c 77-SAo9-,-1:P
7'–073077$UHY J6c9WT
-i -SA!t7f%<&–~0328%Y ,
J6c/-8i0-.J6c-10O/
#J6c-S!BCE7f$Y-$"-S%#K!<
$Y-$"IQ-W-8%Y ,M-#-NKI%#%I
XYN!BC
1.2.2. JY-$M-0Y-P-M--SEJb
21
6^P <IW"8i0kŠ•(l2,
:EJb$S$UW-0[8W!BCEJb
$Y-$"-S%o9K2-N$:-y:-Y #I+
KO-$IT#I+K
$-XkI"&l!BCto-<P$H9M#I+
O-$IT!BCEJb8o$Y--y$L-\70,
=nH!E7f8o "-1:2-1-"O!-1O--%-S
7Œ7--G*'(#20$<:/4W-X-1
,-W-X--1:2-1-"O2-1O--%-S-W-7Œ
!to-<4W-X--<„ˆ$Y-9W
1,EJb!BC
"&]t%-W:0h-SEJb&((-I+
K
O-M--NKk` pl :8%-W
Š'( &((.>*
&(~*u &((.*n
=(~>u >N``N
+K$-X &((.a-8"
=>M-W
1.2.3. A+9"-SEJb
1.2.3.1. A+9"#I+
-O#I+A7ckƒl $: L 8# $N
-7kl072>••I+I+-^Ih$Y--_
>]=-0hEJb&((`-0hcJ=(`!BC
E$U*nN$:L•a?I+$Y-$:LEJb$
22
$Y-8%9"I$NY-,-y=>?I+<
$:LcJk •(!((=l!a•?I+$:LEJb$$Y-
A6c0,Ž W+!k’*((- 7`l,=&?$X
Y$Y-$:LIQcJkG’(!((=l!62:I+
<$:LEJb$sIT<cE4
<$: LcJk•u?4'*?2G—(!(>l!Ej+-U$H
A7c4P-"><$:Lk>=?=n?lj+
1Ac:4$W8U#<$:LEJbk&!>?(?2
G—(!(>l!‚NO*n2='*knn?lH=a•I+
$Y-$:LEJb% [-$:L$U/-P/-S
2 1 Ac2 A7c # N a>2 u•!B C n* $X
Yku&?l8#$N,cJ‰I•$N$:LIQEJb#N
*n2$<a>I+$s-OAJ6c_-^,
4*((- 7`!5NOa>2I+-UmcJ
EJb$4L+-<j+AJ6c0,Ž W+
4P<K$:LEJbm$NkeEE~7~~7
]au?a•?2 —(!(>l2BC
5I+A7ck~l2&a'I+$Y-P-M
_ 2 K $: L &((` EJbk—>'(l - cJ
=(`k—=>'l!BC*nN$:L2a=?I+$:L
EJb$$Y-8%9"I$Nu&?$s-OAJ6c
1 4*((- 7`!E<$Y-$:LIQcJ2-y
*u? •&? I+ $ $Y- 8% 9" 4 P
k ’(!((=l!‚P8W-I+8o-<„ˆX8$Y-9
W1><$:L9,-"+oM-k•u?
a>?lIT<cEkaa?aa?l!‚P1Ac8o
$Y-9W1-"><!
1.2.3.2. Hiêu quả của TDF ở bệnh nhân viêm gan B mạn tính xơ gan
23
E -O a I+ 34 $; @
Ae`A$s-OQ$:LEJb/-$Y-
P-S-"+-W--<„ˆ-W-
87$WW-O-/!E1-"&I+341Ih
$s-^Ih#2#$XYIL8R0W--
i !BCE -49_-W-0+
m > Z + _ # I+ A
A7ckƒlA7ck~l2EJb$s-<$W O hY >
<I+348o34#N*n-S$:L!
BC
1.2.4. ET8WX-EJb
1.2.5. E$"m-SX-
JEJbX-$Y-8$4s12
o:;4X-EJb-S%31 Wm+-Z0[
-I+Ae!EJb$Y-0 X,-y-<W-
0[ [!zs-<:-4$-K,EJb
4PcJ!-ON$$s-OQj+
-V-SK-%W $-*/=n?--">
-ONK ,HX>a=I+
$Y-$:L8%Y cJ~c!BCE$-
K$X,EJb-< N-^%19W!Y
$Y-IW-W$so"$-K#@Ae
$Y-$:LIQEJb2I;-"K-b-!BC
E-ONK ,P"$"-7$s
$Y-9W12-<„ˆ,4#I+K-%$-<
-OEJb!E2-W-$H-yR28o0_,j+
m0hX--4!BCX90$<-N$
!E-ONK 8W-2EJb8o9,P
X-O-/K34,-W-W-8W
24
Ae8W-2N%-W-Y % 3p-,EJb2<K
--<UIL9--W-W-8W-!BCE-4T#
-K EJb2<$Y-I•$N,-8- i >((=2-W-P
8+M$%K$s$Y-IW-W(!'?-S=(2(*&
I+!Ej+ I18}I1-77%$Y-
>!>?! -$I%-OQ-7
%-$UI•$N$:LEJb2X-$-,K2
H%X-49M!6I1:
-O-/KM HI%1$Y-9W1
9N U 2 8 $ -W- -4 # 0 + 2 ]
Kk(!&?l2 -O b-k’(!=?l2 / ;$ -7
Wk’(!=?l!BCEP-21-"-W-I+$:L
IQEJb$Y-8U-O-/Kp-I•$N$:L2
$L8}$<!V-•-70w;$ 7%
!W-W-0[ [8W--N "9[%
2j+•-4P$Y-IW-W# <I+Ae
I+$Y-$:LIQ-W-X-8W8W-!BC
F"•K$34-V$s$Y-IW-W$%-^$
-s!BCE-W-Z+ 7eee#-W-I+
A2EJb00 X!Ej+•--W-P
8+I1Y$Y-W,cJ!to-<T/-7
$"-7’'(` p-W-I+$Y-9
W1!BC
1.3. Ac^-S<I+
1.3.1. ^-SAcI+
Em88WAc$Y- W+% 73W-
K $Y-X+P-<-S8WAcT
@ATP-$sZ0[Ac
011$N-d$WM-@A!
25
ANI-W-3i+M-$:Z0[-W-I8
$LAcT-p-<$-48$LY$
-d9M$NM-I+!
E/N$2:-O-1YAc
-<U "WX„ˆ9M-<:/O
0[P-!#K2+$LYAc
$s#1$:P-S-O!
6;$Ac "WXY%IIL@!T
K-<U-/-O;$Ac$U$WW+9"$:L
Y%U-SI+
